为青少年实施和评估一项纵向糖尿病教育计划
Kristina Loreta Pabedinskas1, Jennilea Courtney2, Nicholas Barrowman1,2
1Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
BMJ open quality
|July 28, 2023
概括
结构化糖尿病教育改善了1型糖尿病 (T1D) 青少年的信心. 糖尿病学习中心 (DLC) 计划显示可行性和高满意度,提高自我管理技能和知识.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 糖尿病 自主管理 教育 教育
- 改善医疗保健的质量
背景情况:
- 国际指导方针倡导持续的教育计划,以提高青少年糖尿病知识和自我效能.
- 儿科糖尿病诊所面临的挑战是为青少年实施结构化,持续的教育干预措施.
研究的目的:
- 实施和评估一个结构化,纵向的教育计划,糖尿病学习中心 (DLC),为1型糖尿病 (T1D) 的青少年.
- 评估参与DLC计划的青少年T1D患者的可行性,患者满意度和对自我管理信心的影响.
主要方法:
- 一个三个阶段的质量改进项目,涉及程序开发,可行性评估 (出席率),以及对信心和满意度的评估.
- 利用利克特尺度来测量基线和干预后对T1D自我管理技能的信心.
- 使用描述性统计和关联分析来了解患者的特征和信心水平.
主要成果:
- 该DLC计划的可行性很高,在符合条件的青少年中,参加率为81%.
- 虽然整体信心是中等的,但特定的自我管理技能显示信心水平较低,与HbA1c高相关.
- 干预后报告了参与者的高满意度 (85%) 和对自我管理技能的信心提高.
结论:
- 一个纵向的T1D教育模式是可行的,并在儿科环境中得到了很好的接受.
- DLC计划有效地解决了教育差距,提高了青少年对糖尿病自我管理的信心和满意度.
- 这个模型提供了一个可复制的模板,用于增强青少年糖尿病护理教育.
相关概念视频
Longitudinal Research
12.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
Longitudinal Studies
187
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
187
Diabetes: Management and Pharmacotherapy
317
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
317
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Insulin: Dosing Regimen and Adverse Effects
211
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
211
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K


